BTA vs Baclofen for Pelvic Myofascial Pain Syndrome (BvsB)
Evaluation of Efficacy and Safety of Oral Baclofen Taking in Comparison With Botulinum Toxin A Injections in Myofascial Pelvic Pain Syndrome. Prospective Multicenter Cohort Study.
Sponsor: Saint Petersburg State University, Russia
Listed as NCT05617118, this observational or N/A phase trial focuses on Chronic Pain and Chronic Pelvic Pain Syndrome and remains ongoing. Sponsored by Saint Petersburg State University, Russia, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
May 2025 — Sep 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2023 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Dec 2022 — May 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Saint Petersburg State University, Russia
- Ural State Medical University
For direct contact, visit the study record on ClinicalTrials.gov .